ATE177147T1 - Säugetier-rezeptoren für interleukin 10 (il-10) - Google Patents

Säugetier-rezeptoren für interleukin 10 (il-10)

Info

Publication number
ATE177147T1
ATE177147T1 AT94903375T AT94903375T ATE177147T1 AT E177147 T1 ATE177147 T1 AT E177147T1 AT 94903375 T AT94903375 T AT 94903375T AT 94903375 T AT94903375 T AT 94903375T AT E177147 T1 ATE177147 T1 AT E177147T1
Authority
AT
Austria
Prior art keywords
receptors
interleukin
mammal
disclosed
therapeutic
Prior art date
Application number
AT94903375T
Other languages
English (en)
Inventor
Kevin W Moore
Ying Liu
Alice Suk-Yue Ho
Di-Hwei Hsu
Jimmy C Tan
Chuan-Chu Chou
J Fernando Bazan
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of ATE177147T1 publication Critical patent/ATE177147T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5428—IL-10
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
AT94903375T 1992-12-10 1993-12-07 Säugetier-rezeptoren für interleukin 10 (il-10) ATE177147T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US98979292A 1992-12-10 1992-12-10
US1106693A 1993-01-29 1993-01-29
US08/110,683 US5789192A (en) 1992-12-10 1993-08-23 Mammalian receptors for interleukin-10 (IL-10)

Publications (1)

Publication Number Publication Date
ATE177147T1 true ATE177147T1 (de) 1999-03-15

Family

ID=27359359

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94903375T ATE177147T1 (de) 1992-12-10 1993-12-07 Säugetier-rezeptoren für interleukin 10 (il-10)

Country Status (14)

Country Link
US (4) US5789192A (de)
EP (1) EP0673420B1 (de)
JP (1) JP3135576B2 (de)
CN (1) CN1052510C (de)
AT (1) ATE177147T1 (de)
AU (1) AU5734094A (de)
CA (1) CA2151141C (de)
DE (1) DE69323765T2 (de)
DK (1) DK0673420T3 (de)
ES (1) ES2129622T3 (de)
GR (1) GR3030038T3 (de)
IL (1) IL107951A (de)
MY (1) MY109045A (de)
WO (1) WO1994013801A1 (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU695869B2 (en) * 1993-04-06 1998-08-27 Fred Hutchinson Cancer Research Center Chimeric cytokine receptors in lymphocytes
WO1995035492A2 (de) * 1994-06-17 1995-12-28 Evotec Biosystems Gmbh Verfahren und vorrichtung zur gezielten entnahme von komponenten aus komplexen mischungen
US5885574A (en) * 1994-07-26 1999-03-23 Amgen Inc. Antibodies which activate an erythropoietin receptor
EP1988166A1 (de) 1997-05-07 2008-11-05 Schering Corporation Menschliche Toll-Like-Rezeptorproteine, zugehörige Reagenzien und Verfahren
US5965704A (en) * 1997-08-05 1999-10-12 Zymogenetics, Inc. Class two cytokine receptor-11
AU2222700A (en) * 1998-12-31 2000-07-31 Millennium Pharmaceuticals, Inc. Class ii cytokine receptor-like proteins and nucleic acids encoding them
US6939545B2 (en) * 1999-04-28 2005-09-06 Genetics Institute, Llc Composition and method for treating inflammatory disorders
EP1181366B2 (de) 1999-06-01 2013-08-21 Merck Sharp & Dohme Corp. Säugetier-rezeptorproteine; ähnliche reagentien und methoden
JP2003508185A (ja) * 1999-08-03 2003-03-04 スミス アンド ネフュー インコーポレーテッド 埋め込み型制御放出装置
US6610286B2 (en) * 1999-12-23 2003-08-26 Zymogenetics, Inc. Method for treating inflammation using soluble receptors to interleukin-20
US7122632B2 (en) * 1999-12-23 2006-10-17 Zymogenetics, Inc. Soluble Interleukin-20 receptor
WO2001064713A2 (en) * 2000-03-01 2001-09-07 Christoph Gasche Mammalian interleukin-10 (il-10) receptor variants
EP1283722A1 (de) * 2000-03-31 2003-02-19 Idec Pharmaceuticals Corporation Kombinierte verwendung von anti-zytokin-antikörpern oder antagonisten und anti-cd20 zur behandlung von b-zell-lymphomen
US6756481B2 (en) 2000-05-10 2004-06-29 Schering Corporation IL-23 receptor binding compositions
AU2001290524A1 (en) * 2000-08-08 2002-02-18 Zymogenetics Inc. Soluble zcytor 11 cytokine receptors
ATE333888T1 (de) * 2000-09-15 2006-08-15 Zymogenetics Inc Verwendung eines polypeptids, welches die extrazelluläre domäne von il-20ra und il-20rb enthält, zur behandlung von entzündungen
US6890734B2 (en) 2000-11-10 2005-05-10 Schering Corporation Nucleic acids encoding a cytokine receptor complex
US7638604B2 (en) * 2001-02-23 2009-12-29 Genetics Institute, Llc Monoclonal antibodies against interleukin-22
WO2003051384A1 (en) * 2001-12-17 2003-06-26 Zymogenetics, Inc. Method for treating cervical cancer
US20060063156A1 (en) * 2002-12-06 2006-03-23 Willman Cheryl L Outcome prediction and risk classification in childhood leukemia
DE602004028347D1 (de) * 2003-03-24 2010-09-09 Zymogenetics Inc Anti-il-22ra antikörper und bindungspartner und verwendungsmethoden bei entzündung
WO2005024027A1 (ja) * 2003-09-02 2005-03-17 National Institute Of Advanced Industrial Science And Technology 抗体医薬
EP1697418A2 (de) * 2003-11-21 2006-09-06 ZymoGenetics, Inc. Anti-il-20-rezeptor-antikörper und bindungspartner und verfahren zur anwendung bei entzündungen
US20050132599A1 (en) * 2003-12-18 2005-06-23 Lg Electronics Inc. Drying method of washing machine and apparatus thereof
EA015706B1 (ru) * 2004-10-22 2011-10-31 Займоджинетикс, Инк. Моноклональное антитело или его фрагмент, связывающиеся с полипептидом il-22ra, гуманизированное антитело, полученное из указанного антитела, гибридомы, продуцирующие антитело, и применение указанного антитела
US20060177883A1 (en) 2005-02-08 2006-08-10 Saladax Biomedical Inc. 5-Fluoro-uracil immunoassay
EP1712241A1 (de) * 2005-04-15 2006-10-18 Centre National De La Recherche Scientifique (Cnrs) Intratumoral applizierbare Zusammensetzung zur Krebsbehandlung
TWI417301B (zh) 2006-02-21 2013-12-01 Wyeth Corp 對抗人類介白素-22(il-22)之抗體及其用途
TW200744634A (en) * 2006-02-21 2007-12-16 Wyeth Corp Methods of using antibodies against human IL-22
SI3409289T1 (sl) 2010-02-26 2020-12-31 Novo Nordisk A/S Stabilni sestavki, ki vsebujejo protitelo
RU2012153786A (ru) 2010-05-28 2014-07-10 Ново Нордиск А/С Стабильные многодозовые композиции, содержащие антитело и консервант
EP3288965B1 (de) * 2015-04-29 2019-06-26 Mediolanum Farmaceutici S.p.A. Un récepteur chimere de l'interleukine soluble et son utilisation thérapeutique
CN113125730B (zh) * 2019-12-31 2023-07-07 科美博阳诊断技术(上海)有限公司 一种白介素6的均相检测试剂盒及其应用

Also Published As

Publication number Publication date
EP0673420A1 (de) 1995-09-27
US5985828A (en) 1999-11-16
HK1008830A1 (en) 1999-05-21
US5863796A (en) 1999-01-26
US6423500B1 (en) 2002-07-23
JP3135576B2 (ja) 2001-02-19
JPH07509613A (ja) 1995-10-26
MY109045A (en) 1996-11-30
US5789192A (en) 1998-08-04
CN1052510C (zh) 2000-05-17
ES2129622T3 (es) 1999-06-16
IL107951A0 (en) 1994-04-12
GR3030038T3 (en) 1999-07-30
CA2151141C (en) 2001-07-17
DK0673420T3 (da) 1999-10-04
CN1090326A (zh) 1994-08-03
AU5734094A (en) 1994-07-04
DE69323765T2 (de) 1999-07-22
IL107951A (en) 2003-12-10
DE69323765D1 (de) 1999-04-08
CA2151141A1 (en) 1994-06-23
EP0673420B1 (de) 1999-03-03
WO1994013801A1 (en) 1994-06-23

Similar Documents

Publication Publication Date Title
DE69323765D1 (de) Säugetier-rezeptoren für interleukin 10 (il-10)
MY157028A (en) Mammalian cytokine, related reagents
AU639226B2 (en) Recombinant protein receptor
ATE142645T1 (de) Rezeptoren für wachstumshormone
EP0174366A4 (de) T-zellenrezeptor, spezifisch für antigenpolypeptide und verwandte polynukleotide.
IL124728A0 (en) Diagnosis and treatment of aur-1 and/or aur-2 related disorders
ATE397660T1 (de) Zelloberflächen-antigen aus säugetieren und verwandte reagenzien
DE69836630D1 (de) Menschliche toll-ähnliche rezeptorproteine, zugehörige reagenzien und verfahren
ATE196775T1 (de) Gereinigte flt3 liganden von saeugentieren, agonisten und antagonisten davon
ATE265533T1 (de) Saeugetierchemokine
WO2001064713A3 (en) Mammalian interleukin-10 (il-10) receptor variants
WO1998032858A3 (en) Mammalian chemokines; receptors; reagents; uses
DE69534178D1 (en) S?ugetier thymokingene
WO1998031810A3 (en) Mammalian chemokines; receptors; reagents; uses
WO1992016623A3 (en) Receptors for bombesin-like peptides
DE59009360D1 (de) Für das Plazentaprotein 9 (PP9) kodierende cDNA, ihre Isolierung und Verwendung.
AR041564A1 (es) Genes aislados de proteinas de membrana de mamiferos reactivos relacionados

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee